ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1040

Clinical Characteristics of Sarcoidosis in Asian Population: A 14-year Single Center Retrospective Cohort Study from Thailand

Athiwat Tripipitsiriwat1, Chulaluk Komoltri1, Ruchira Ruangchira-Urai1 and Patompong Ungprasert2, 1Mahidol University, Bangkok, Thailand, 2Cleveland Clinic, Cleveland, OH, Cleveland Heights, OH

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, Epidemiology, pulmonary

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster II: Sarcoidosis, Interstitial Lung Disease, & Inflammatory Eye Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Data on clinical manifestations of Asians with sarcoidosis are still relatively limited and most of the previously published studies are from East Asia. This study aimed to examine the epidemiology and clinical characteristics of Thai patients with sarcoidosis, using databases of a tertiary care medical center.

Methods: Potential cases of sarcoidosis were identified from two sources, the medical record-linkage system and the pathology database of Siriraj Hospital, Mahidol University in Bangkok, Thailand.  Patients with ICD-10-CM codes for sarcoidosis were identified and retrieved from the medical record-linkage system from 2005 to 2018.  Patients with histopathology positive for non-caseating granuloma were identified and retrieved from the pathology database from the same time period.  All potential cases underwent individual medical record review to confirm the diagnosis of sarcoidosis which required compatible clinical pictures supported by presence of non-caseating granuloma after exclusion of other granulomatous diseases. A standardized case record form was used to record demographics, clinical manifestations and treatment of confirmed sarcoidosis cases.

Results: From 2005 to 2018, 89 confirmed cases of sarcoidosis were identified.  There was female predominance (80.9%) with mean age at diagnosis of 46.8 years (standard deviation [SD] 13.9 years) and mean follow-up time of 5.4 years (SD 4.5 years).  The majority of patients with sarcoidosis in this cohort had intrathoracic disease (81 cases; 91.0%).  About half of them had stage I pulmonary sarcoidosis (43 cases; 53.1%) followed by stage II (32 cases; 39.5%), III (5 cases; 6.2%) and IV (1 case; 1.2%).  However, less than half of patients with intrathoracic disease were symptomatic (34 cases; 41.9%) with dyspnea and cough being the most common symptoms (25.9% and 22.2%, respectively).  The yield of intrathoracic biopsy was fair that histopathology was positive for non-caseating granuloma in 53 of 68 patients (77.9%) who underwent biopsy.

Extrathoracic disease was common in this cohort that pulmonary sarcoidosis was accompanied by extrathoracic involvement in 53 patients (65.4%).  Isolated extrathoracic disease was observed in 8 patients.  Sarcoid uveitis was the most common extrathoracic disease (35 cases; 39.3%; 4 males and 31 females) followed by cutaneous sarcoidosis (24 cases; 26.9%).  Calcium was tested in 56 patients and hypercalcemia was seen in 9 of them (16.1%).  Biopsy of extrathoracic organs appeared to have a high sensitivity with 21 of 22 skin biopsies and all 8 extrathoracic lymph node biopsies showed evidence of non-caseating granuloma.
  
A total of 48 patients (53.9%) received at least one systemic treatment during the course of their illness.  The most commonly prescribed systemic treatment was oral prednisolone (46 cases; 51.7%) followed by methotrexate (16 cases; 17.9%), azathioprine (8 cases; 9.0%) and chloroquine (3 cases; 3.4%) (Table 1).

Conclusion: The current study described clinical characteristics of sarcoidosis in an Asian population. The most prominent findings that are different from sarcoidosis in other ethnic groups included the high prevalence of uveitis and the marked female predominance. 

Table 1: Characteristics of patient with sarcoidosis in the current study


Disclosure: A. Tripipitsiriwat, None; C. Komoltri, None; R. Ruangchira-Urai, None; P. Ungprasert, None.

To cite this abstract in AMA style:

Tripipitsiriwat A, Komoltri C, Ruangchira-Urai R, Ungprasert P. Clinical Characteristics of Sarcoidosis in Asian Population: A 14-year Single Center Retrospective Cohort Study from Thailand [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/clinical-characteristics-of-sarcoidosis-in-asian-population-a-14-year-single-center-retrospective-cohort-study-from-thailand/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-of-sarcoidosis-in-asian-population-a-14-year-single-center-retrospective-cohort-study-from-thailand/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology